Found 56 matching trials
Study of A Venetoclax-based, Anthracycline-free Regimen in Newly Diagnosed CBFβ::MYH11(+) AML PHASE2 This investigator-initiated, single-arm, phase II trial is aimed to evaluat...
Show More Location
Ethical Committee of the First Affiliated Hospital of Soochow University
Learn More & Join Trial
Comparison of the Efficacy and Safety of Venetoclax in Combination With 3 Days Decitabine (DEC3-VEN) vs. Venetoclax in Combination With Azacitidine (VIALE-A) in the Treatment of Elderly Patients or Unfit, New-diagnosis Acute Myeloid Leukemia Patients PHASE3 Combining the results of previous studies and based on the clinical practic...
Show More Location
The Second Affiliated Hospital of Kunming Medical University.
Learn More & Join Trial
Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD PHASE2 The purpose of this research study is to see if people whose Acute myeloid ...
Show More Location
Moffitt Cancer Center
Learn More & Join Trial
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) PHASE3 The purpose of this study is to assess how bleximenib and Venetoclax (VEN)+...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR) PHASE2 Open-label phase II, single arm, multicenter study with safety run-in to ev...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia PHASE2 This study is to investigate the therapeutic efficacy and side effect of ve...
Show More Location
The First Affliated Hospital of Soochow University
Learn More & Join Trial
HMA-Venetoclax Induction in Newly Diagnosed AML PHASE2 Acute myeloid leukaemia (AML) is a clonal haematological malignancy charact...
Show More Location
National University of Medical Sciences, Clinical Trial Unit
Learn More & Join Trial
IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study) PHASE2 This phase II study compares the order of treatment with ivosidenib or enas...
Show More Location
University of Colorado
Learn More & Join Trial
Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven NA The study proposes to correlate the plasma dosage of VEN with the inhibitio...
Show More Location
Hopital la Conception
Learn More & Join Trial
Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Lymphoblastic Leukemia Undergoing Allo-HSCT PHASE2 The purpose of this prospective, open-label, single-center study is to eval...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial